Gilead Sciences

Gilead Sciences News

COVID-19 treatment: Fabiflu by Glenmark, HCQ, Remdesivir and other drugs that are being used to treat coronavirus patients
India

COVID-19 treatment: Fabiflu by Glenmark, HCQ, Remdesivir and other drugs that are being used to treat coronavirus patients

Favipiravir is an antiviral drug which was developed by a Japanese pharma company, Fujifilm Toyama Chemical, to treat influenza.

Coronavirus Outbreak: Gilead Sciences says supply of Remdesivir to exceed 20 lakh by end of the year
World

Coronavirus Outbreak: Gilead Sciences says supply of Remdesivir to exceed 20 lakh by end of the year

Gilead Sciences Inc expects supply of its potential COVID-19 drug Remdesivir to exceed twenty lakh courses by year-end, the company said on Monday, more than double its previous target of 10 lakh.

Stock Market Latest Updates: Indices nearly 3-month high, Sensex jumps over 500 points, Nifty close to 10,000-mark; Bajaj Finance, HDFC among gainers
Business

Stock Market Latest Updates: Indices nearly 3-month high, Sensex jumps over 500 points, Nifty close to 10,000-mark; Bajaj Finance, HDFC among gainers

Stock Market Latest Updates: Indices nearly 3-month high, Sensex jumps over 500 points, Nifty close to 10,000-mark; Bajaj Finance, HDFC among gainers

Cipla inks licensing pact with Gilead Sciences for potential COVID-19 treatment drug remdesivir
Business

Cipla inks licensing pact with Gilead Sciences for potential COVID-19 treatment drug remdesivir

Homegrown pharma major Cipla Ltd on Wednesday said it has signed a non-exclusive licensing agreement with Gilead Sciences Inc for manufacturing and distribution of investigational drug remdesivir, a potential therapy for COVID-19

India's Jubilant Life inks licensing agreement with Gilead to manufacture Remdesivir, a potential drug to treat COVID-19
Business

India's Jubilant Life inks licensing agreement with Gilead to manufacture Remdesivir, a potential drug to treat COVID-19

Jubilant Life Sciences Ltd on Tuesday said it has entered into a non-exclusive licensing agreement with Gilead Sciences, Inc that will grant it the right to register, manufacture and sell the latter's investigational drug, remdesivir

Hetero inks licensing agreement with Gilead for manufacturing, distribution of remdesivir
Business

Hetero inks licensing agreement with Gilead for manufacturing, distribution of remdesivir

Domestic pharma major Hetero on Wednesday said it has entered into a licensing agreement with Gilead Sciences Inc for manufacturing and distribution of remdesivir, a potential therapy for COVID-19

Gilead ties up with 5 generic drugmakers in India, Pakistan for COVID-19 drug supply; licensees to set price for product
Business

Gilead ties up with 5 generic drugmakers in India, Pakistan for COVID-19 drug supply; licensees to set price for product

Gilead’s antiviral drug remdesivir earlier this month received the US Food and Drug Administration’s emergency use authorization to treat COVID-19 patients.

Four things you need to know about Remdesivir, the FDA-approved drug for severe COVID-19 cases
Health

Four things you need to know about Remdesivir, the FDA-approved drug for severe COVID-19 cases

Remdesivir is a broad-spectrum antiviral medicine that has got significant public attention for its possible benefits in the treatment of COVID-19.

US Food and Drug Administration allows emergency use of intravenous drug Remdesivir for patients hospitalised with COVID-19
World

US Food and Drug Administration allows emergency use of intravenous drug Remdesivir for patients hospitalised with COVID-19

The Food and Drug Administration cleared Gilead Science’s Remdesivir for hospitalised patients with “severe disease,” such as those experiencing breathing problems requiring supplemental oxygen or ventilators.

Coronavirus Outbreak: US president Donald Trump and Anthony Fauci see hope in Gilead's drug Remdesivir
World

Coronavirus Outbreak: US president Donald Trump and Anthony Fauci see hope in Gilead's drug Remdesivir

Dr Anthony Fauci, though, told reporters during a White House meeting with Donald Trump that the data on the drug, Remdesivir, needs to be further analysed.

Gilead's anti-viral drug Remdesivir succeeds in coronavirus treatment trial, company says medicine will prove helpful if given early
Health

Gilead's anti-viral drug Remdesivir succeeds in coronavirus treatment trial, company says medicine will prove helpful if given early

Gilead Sciences Inc’s experimental antiviral drug remdesivir helped improve symptoms in COVID-19 patients who were given the drug early than among those who were treated later, the company said.

Gilead rubbishes claim that antiviral drug, Remdesivir, failed to help Coronavirus patients in Chinese trial
World

Gilead rubbishes claim that antiviral drug, Remdesivir, failed to help Coronavirus patients in Chinese trial

Doctors suggest antiviral drugs would be most effective when administered as early as possible as it helps keep the virus from replicating in the blood.

Coronavirus Outbreak: Leaked results of a clinical trial hints Gliead's Remdesivir could be possible COVID-19 cure
World

Coronavirus Outbreak: Leaked results of a clinical trial hints Gliead's Remdesivir could be possible COVID-19 cure

During the trial, 113 patients were treated with the drug, most were discharged from the hospital in under a week, and only two died.

Stock market gains alongside economic pain driven by massive boost from Fed; some worry about over-optimism
Business

Stock market gains alongside economic pain driven by massive boost from Fed; some worry about over-optimism

The US stock market has changed its mood swiftly since 23 March—when the S&P 500 dropped as much as 35 percent below its 19 February peak.

Wall Street gains after reports of Boeing to resume production next week; investors cheer Trump's plan to reopen economy
Business

Wall Street gains after reports of Boeing to resume production next week; investors cheer Trump's plan to reopen economy

Boeing's shares soared 11.7 percent on plans to resume commercial aircraft production in Washington state after halting operations last month due to the coronavirus pandemic

CAR-T revolution: Radical new cancer cure offers better efficiency, one-and-done solution
science

CAR-T revolution: Radical new cancer cure offers better efficiency, one-and-done solution

The FDA-approved treatment is available to patients of certain types of cancer and their insurance coverage.

Gilead to challenge hepatitis C drug patent rejection
Business

Gilead to challenge hepatitis C drug patent rejection

An order by deputy controller of patents and designs Hardev Karar has said Gilead, which sells the drug under the Sovaldi brand in the US, failed to prove that there were enhancement of therapeutic efficacy in the new discovery.